Evidence map›Paper›PMID 38818705›Full record

ArticleChemical communications (Cambridge, England)2024

Cell viability imaging in tumor spheroids

Vadde Ramu, Lukas S Wijaya, Nataliia Beztsinna, Corjan Van de Griend, Bob van de Water, Sylvestre Bonnet, Sylvia E Le Dévédec

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemical communications (Cambridge, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Imaging nucleic acids in biofilms.Essays in biochemistry · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. A Simple Model to Study Mosaic Gene Expression in 3D Endothelial Spheroids.Journal of cardiovascular development and disease · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vadde RamuLeiden Institute of Chemistry, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands. ramuvadde1@gmail.com.ORCID http://orcid.org/0000-0003-0726-6920
Lukas S WijayaLeiden Academic Center for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands. s.e.ledevedec@lacdr.leidenuniv.nl.ORCID http://orcid.org/0000-0003-0646-9267
Nataliia BeztsinnaLeiden Institute of Chemistry, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands. ramuvadde1@gmail.com.
Corjan Van de GriendLeiden Institute of Chemistry, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands. ramuvadde1@gmail.com.
Bob van de WaterLeiden Academic Center for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands. s.e.ledevedec@lacdr.leidenuniv.nl.ORCID http://orcid.org/0000-0002-5839-2380
Sylvestre BonnetLeiden Institute of Chemistry, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands. ramuvadde1@gmail.com.ORCID http://orcid.org/0000-0002-5810-3657
Sylvia E Le DévédecLeiden Academic Center for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands. s.e.ledevedec@lacdr.leidenuniv.nl.ORCID http://orcid.org/0000-0002-0615-9616

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The famous ''light-switch'' ruthenium complex [Ru(bpy)

Indexed as

Cell SurvivalCoordination ComplexesDNARutheniumSpheroids, CellularCell Line, TumorFluorescent DyesHumansLightOptical ImagingOrganometallic CompoundsCoordination ComplexesDNAFluorescent DyesOrganometallic CompoundsRuthenium

Identifiers

PMID38818705
PMCPMC11181008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.